[1]
Williams R. The elusive goal of liver support--quest for the Holy Grail. Clinical medicine (London, England). 2006 Sep-Oct:6(5):482-7
[PubMed PMID: 17080897]
[2]
Sen S, Mookerjee RP, Davies NA, Williams R, Jalan R. Review article: the molecular adsorbents recirculating system (MARS) in liver failure. Alimentary pharmacology & therapeutics. 2002 Dec:16 Suppl 5():32-8
[PubMed PMID: 12423451]
[3]
Podoll AS, DeGolovine A, Finkel KW. Liver support systems--a review. ASAIO journal (American Society for Artificial Internal Organs : 1992). 2012 Sep-Oct:58(5):443-9. doi: 10.1097/MAT.0b013e31825f3446. Epub
[PubMed PMID: 22820917]
[4]
Mitzner SR. Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS). Annals of hepatology. 2011 May:10 Suppl 1():S21-8
[PubMed PMID: 21566251]
[5]
Mielnicki W, Dyla A, Karczewski M. Clinical effectiveness of MARS treatment - multidirectional analysis of positive clinical response to treatment. Clinical and experimental hepatology. 2019 Nov:5(4):271-278. doi: 10.5114/ceh.2019.89163. Epub 2019 Oct 18
[PubMed PMID: 31893237]
[6]
Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, Klammt S, Peszynski P, Freytag J, Hickstein H, Löhr M, Liebe S, Schareck W, Hopt UT, Schmidt R. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artificial organs. 1999 Apr:23(4):319-30
[PubMed PMID: 10226696]
[7]
García Martínez JJ, Bendjelid K. Artificial liver support systems: what is new over the last decade? Annals of intensive care. 2018 Nov 15:8(1):109. doi: 10.1186/s13613-018-0453-z. Epub 2018 Nov 15
[PubMed PMID: 30443736]
[8]
Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, Nöldge-Schomburg G. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. Journal of the American Society of Nephrology : JASN. 2001 Feb:12 Suppl 17():S75-82
[PubMed PMID: 11251037]
[9]
Kapoor D. Molecular adsorbent recirculating system: albumin dialysis-based extracorporeal liver assist device. Journal of gastroenterology and hepatology. 2002 Dec:17 Suppl 3():S280-6
[PubMed PMID: 12472950]
[10]
Boyle M, Kurtovic J, Bihari D, Riordan S, Steiner C. Equipment review: the molecular adsorbents recirculating system (MARS). Critical care (London, England). 2004 Aug:8(4):280-6
[PubMed PMID: 15312211]
[11]
Sen S, Jalan R, Williams R. Liver failure: basis of benefit of therapy with the molecular adsorbents recirculating system. The international journal of biochemistry & cell biology. 2003 Sep:35(9):1306-11
[PubMed PMID: 12798344]
[12]
Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, Verslype C, Fevery J, Nevens F. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Critical care (London, England). 2006:10(4):R108
[PubMed PMID: 16859530]
[13]
Parés A, Deulofeu R, Cisneros L, Escorsell A, Salmerón JM, Caballería J, Mas A. Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure. Critical care (London, England). 2009:13(1):R8. doi: 10.1186/cc7697. Epub 2009 Jan 28
[PubMed PMID: 19175915]
[14]
Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R. Albumin dialysis using the molecular adsorbent recirculating system. Current opinion in nephrology and hypertension. 2001 Nov:10(6):777-83
[PubMed PMID: 11706305]
Level 3 (low-level) evidence
[15]
Gerth HU, Pohlen M, Thölking G, Pavenstädt H, Brand M, Hüsing-Kabar A, Wilms C, Maschmeier M, Kabar I, Torner J, Pavesi M, Arroyo V, Banares R, Schmidt HHJ. Molecular Adsorbent Recirculating System Can Reduce Short-Term Mortality Among Patients With Acute-on-Chronic Liver Failure-A Retrospective Analysis. Critical care medicine. 2017 Oct:45(10):1616-1624. doi: 10.1097/CCM.0000000000002562. Epub
[PubMed PMID: 28640024]
Level 2 (mid-level) evidence
[16]
Bañares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, Saliba F, Sauerbruch T, Klammt S, Ockenga J, Pares A, Wendon J, Brünnler T, Kramer L, Mathurin P, de la Mata M, Gasbarrini A, Müllhaupt B, Wilmer A, Laleman W, Eefsen M, Sen S, Zipprich A, Tenorio T, Pavesi M, Schmidt HH, Mitzner S, Williams R, Arroyo V, RELIEF study group. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology (Baltimore, Md.). 2013 Mar:57(3):1153-62. doi: 10.1002/hep.26185. Epub 2013 Feb 15
[PubMed PMID: 23213075]
[17]
Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, Hickstein H, Loock J, Löhr JM, Liebe S, Emmrich J, Korten G, Schmidt R. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2000 May:6(3):277-86
[PubMed PMID: 10827226]
Level 1 (high-level) evidence
[18]
Leise MD, Poterucha JJ, Kamath PS, Kim WR. Management of hepatic encephalopathy in the hospital. Mayo Clinic proceedings. 2014 Feb:89(2):241-53. doi: 10.1016/j.mayocp.2013.11.009. Epub 2014 Jan 8
[PubMed PMID: 24411831]
[19]
Saliba F. The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure. Critical care (London, England). 2006 Feb:10(1):118
[PubMed PMID: 16542471]
[21]
Tan HK. Molecular adsorbent recirculating system (MARS). Annals of the Academy of Medicine, Singapore. 2004 May:33(3):329-35
[PubMed PMID: 15175774]
[22]
Hanish SI, Stein DM, Scalea JR, Essien EO, Thurman P, Hutson WR, Bartlett ST, Barth RN, Scalea TM. Molecular Adsorbent Recirculating System Effectively Replaces Hepatic Function in Severe Acute Liver Failure. Annals of surgery. 2017 Oct:266(4):677-684. doi: 10.1097/SLA.0000000000002361. Epub
[PubMed PMID: 28692474]
[23]
Fagugli RM, Gentile G, Ferrara G, Brugnano R. Acute renal and hepatic failure associated with allopurinol treatment. Clinical nephrology. 2008 Dec:70(6):523-6
[PubMed PMID: 19049711]
[24]
Prokurat S, Grenda R, Lipowski D, Kaliciński P, Migdal M. MARS procedure as a bridge to combined liver-kidney transplantation in severe chromium-copper acute intoxication: a paediatric case report. Liver. 2002:22 Suppl 2():76-7
[PubMed PMID: 12220311]
Level 3 (low-level) evidence
[25]
Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. Journal of hepatology. 1999 Dec:31(6):1080-5
[PubMed PMID: 10604583]
[26]
Sen S, Ratnaraj N, Davies NA, Mookerjee RP, Cooper CE, Patsalos PN, Williams R, Jalan R. Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Epilepsia. 2003 Feb:44(2):265-7
[PubMed PMID: 12558586]
[27]
Korsheed S, Selby NM, Fluck RJ. Treatment of severe theophylline poisoning with the molecular adsorbent recirculating system (MARS). Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2007 Mar:22(3):969-70
[PubMed PMID: 17164319]
[28]
Mecarelli O, Pulitano P, Mingoia M, Ferretti G, Rossi M, Berloco PB, Muda AO. Acute hepatitis associated with lamotrigine and managed with the molecular adsorbents recirculating system (Mars). Epilepsia. 2005 Oct:46(10):1687-9
[PubMed PMID: 16190944]
[29]
Di Campli C, Zileri Dal Verme L, Andrisani MC, Armuzzi A, Candelli M, Gaspari R, Gasbarrini A. Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure. Current medicinal chemistry. 2003 Feb:10(4):341-8
[PubMed PMID: 12570706]
Level 3 (low-level) evidence